ACHE and Alzheimer disease: Three acetylcholinesterase inhibitors (donepezil, rivastigmine, and galantamine) are recommended as options in the treatment of patients with mild to moderate AD; and memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist, is licensed for the management of patients with moderate to severe AD.